Proteomics International Laboratories’ blood test uses biomarkers to diagnose oesophageal adenocarcinoma and the pre-malignant condition, Barrett’s oesophagus, to detect the disease sooner and potentially improving health outcomes.
Article: Early Oesophageal Cancer Diagnosis Now Closer for At-Risk
